Absolute configuration determination of isoflavan-4-ol stereoisomers

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 15, 2010, Pages 4337-4341

  Kim, Mihyang ^a   Won, Dongho ^a   Han, Jaehong ^a  

^a Chung Ang University   (South Korea)

Author keywords

ECD; Equol; Flavonoids; Stereochemistry; TD DFT; VCD

Indexed keywords

FLAVONOID; ISOFLAVAN 4 OL; ISOFLAVAN DERIVATIVE; S EQUOL; TETRAHYDRODAIDZEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CHEMICAL MODIFICATION; CIRCULAR DICHROISM; CONTROLLED STUDY; DENSITY FUNCTIONAL THEORY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG POTENCY; ELECTRONIC CIRCULAR DICHROISM SPECTROSCOPY; STEREOCHEMISTRY; STEREOISOMERISM; TIME DEPENDENT DENSITY FUNCTIONAL THEORY; VIDEO CIRCULAR DICHROISM SPECTROSCOPY;

CIRCULAR DICHROISM; ISOFLAVONES; MOLECULAR CONFORMATION; STEREOISOMERISM;

EID: 77954180759     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.06.074     Document Type: Article

References (23)

1. E.L. Eliel, S.H. Wilen, Stereochemistry of Organic Compounds 1994 John Wiley and Sons New York
2. R.R. Frase J.D. Morrison, Asymmetric Synthesis 1983 Academic Press New York Chapter 9
3. G. Snatzke Tetrahedron 21 1965 413
4. G. Snatzke, F. Znatzke, A.L. Tökés, M. Rákosi, and R. Bognár Tetrahedron 29 1973 909
5. J.K. Gawronski, M. Kwit, D.R. Boyd, N.D. Sharma, J.F. Malone, and A.F. Drake J. Am. Chem. Soc. 127 2005 4308
6. L.A. Nafie Nat. Prod. Commun. 3 2008 451
7. T.B. Freedman, X. Cao, R.K. Dukore, and L.A. Nafie Chirality 15 2003 743
8. D. Won, B.-K. Shin, S. Kang, H.-G. Hur, M. Kim, and J. Han Bioorg. Med. Chem. Lett. 18 2008 1952
9. M. Kim, S.-I. Kim, J. Han, X.-L. Wang, D.-G. Song, and S.-U. Kim Appl. Environ. Microbiol. 75 2009 3062
10. N. Sathyamoorthy, and T.T.Y. Wang Eur. J. Cancer 33 1997 2384
11. K.D.R. Setchell, C. Clerici, E.D. Lephart, S.J. Cole, C. Heenan, D. Castellani, B.E. Wolfe, L. Nechemias-Zimmer, N.M. Brown, T.D. Lund, R.J. Handa, and J.E. Heubi Am. J. Clinic. Nutr. 81 2005 1072
12. L. Kiss, T. Kurtan, S. Antus, and A. Benyei Chirality 15 2003 558
13. M.J.S. Dewar, E.G. Zoebisch, E.F. Healy, and J.J.P. Stewart J. Am. Chem. Soc. 107 1985 3902
14. K. Wähälä, J.K. Koskimies, M. Mesilaakso, A. Salakka, T.K. Leino, and H. Adlercreutz J. Org. Chem. 62 1997 7690
15. K. Pihlaja, P. Tähtinen, K.D. Klika, T. Jokela, A. Salakka, and K. Wähälä J. Org. Chem. 68 2003 6864
16. J. Seo, S.I. Kang, J.Y. Ryu, Y.J. Lee, K.D. Park, M. Kim, D. Won, H.Y. Park, J.H. Ahn, Y. Chong, R.A. Kanaly, J. Han, and H.G. Hur Appl. Microbiol. Biotechnol. 86 2010 1451
17. J. Seo, S.I. Kang, M. Kim, D. Won, H. Takahashi, J.H. Ahn, Y. Chong, E. Lee, Y. Lim, R.A. Kanaly, J. Han, and H.G. Hur Anal. Biochem. 397 2010 29
18. Each enantiomer was designated as T-1 and T-2 for trans-isoflavan-4-ols, and C-1 and C-2 for cis-isoflavan-4-ols, respectively, according to the elution order on the Sumi-chiral column chromatogram. See Ref. 8 for HPLC chromatogram of the stereoisomers.
19. L.A. Nafie, R.K. Dukor, and T.B. Freedman J.M. Chalmers, P.R. Griffiths, 2002 John Wiley and Sons New York 731 744
20. J.R. Cheeseman, M.J. Frisch, F.J. Devlin, and P.J. Stephens Chem. Phys. Lett. 252 1996 211
21. Y. Kan, M. Satake, and T. Yasumoto Tetrahedron Lett. 37 1996 7087
22. T. Kusumi, H. Takahashi, P. Xu, T. Fukushima, Y. Asakawa, T. Hashimoto, Y. Kan, and Y. Inouye Tetrahedron Lett. 35 1994 4397
23. 3), 43.58 (C-3).